Close Menu

NEW YORK – Abbott announced after the close of the market on Wednesday that its molecular test for SARS-CoV-2 has received Emergency Use Authorization from the US Food and Drug Administration.

The Abbott RealTime SARS-CoV-2 EUA test runs on the company's PCR-based m2000 RealTime System. The company said it would work with health systems and government authorities to distribute additional instruments where needed. Right now, there are more than 175 PCR m2000 instruments in the US, each one able to run up to 470 tests in 24 hours. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Science reports that a new White House Office of Management and Budget memo rescinds previous ones that helped research institutions deal with pandemic-related closures.

Researchers report on a concerning strain of the H1N1 swine flu virus found among pigs in China, Agence France Presse reports.

The Associated Press reports that US officials are considering allowing pooled COVID-19 testing.

In Genome Research this week: Y chromosome gene expression analysis, de novo mutations rise with paternal age in rhesus macaques, and more.